As healthcare costs rise in Florida, insurers and hospitals vested in the success of the Affordable Care Act, are coming up with new ways to cut costs from buying services in bulk and piloting programs to lowering hospital readmission rates and limiting the number of doctors within a plan's network.
As health care costs rise in Florida, insurers and hospitals vested in the success of the Affordable Care Act, are coming up with new ways to cut costs from buying services in bulk and piloting programs to lowering hospital readmission rates and limiting the number of doctors within a plan's network.
Florida's health care costs is rising an average of 6.9 percent a year, higher than the national average of 6.5 percent. Health care expenditures per capita in the state are $7,156 compared to the national average of $6,815 during that same time period, according to the nonpartisan Kaiser Family Foundation. Reining in health care costs, which have been growing far faster than inflation and wages, will be crucial to the long-term success of the Affordable Care Act.
President Barack Obama has repeatedly stressed that health care reforms will give more people access to affordable coverage no matter their age, income or medical history. Insurers will have to offer more benefits in some cases and are restricted in how much they can charge older, sicker people. Insurers are also banned from turning away those with pre-existing conditions. But if the federal health law is successful, it will mean more customers for insurers and more paying patients for hospitals, giving them more incentive to experiment with different ways of paying doctors and delivering care in an industry with already shrinking profit margins.
Read the full story here: http://bit.ly/17p0RfQ
Source: SFGate
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More